Biggest APAC funding rounds, week ending 21st August

Updated August 2026. By Remy Beaumont.

Total raised in APAC this week: approximately $850m+ across 10+ disclosed rounds, dominated by Blackbird's AUD 1.05bn fund close and CCSH/YMTC's $4.9bn IPO filing.

Key takeaways

• Blackbird closed AUD 1.05bn ($751m), the largest venture capital fund raise in Australian and New Zealand history, backed by Morgan Stanley, Adams Street, Schroders, and sovereign investors.

• CCSH Corporation (parent of YMTC) filed for a $4.9bn Shanghai IPO, China's second mega-chip listing after CXMT's $8.6bn raise in July. Not a startup round, but the defining capital market event of the APAC week.

• Kembangan Capital Partners (KCP) raised $725m at first close for Asia-focused fund-of-funds and direct investments, anchored by an unnamed sovereign wealth fund.

• India produced the largest disclosed startup equity round: Craif ($33m Series D, Tokyo-based but with US and Japan deployment), while China disclosed multiple eight-figure RMB venture rounds.

• The week's capital activity was dominated by fund-level and public-market events (Blackbird, KCP, CCSH) rather than individual startup rounds, a structural shift from the prior week's India-dominated startup picture.

What did the APAC funding week look like?

The week ending 21st August 2026 produced a qualitatively different APAC funding picture from recent weeks. Instead of a single $2bn data centre round (Firmus, two weeks ago) or a cluster of Indian Series B and C rounds dominating the total, this week's capital activity concentrated at the fund and IPO level. Blackbird's record fund close, KCP's sovereign-backed vehicle, and CCSH's IPO filing collectively moved billions without any single startup round exceeding $35m.

That structural shift matters for how founders read the market. When capital is flowing into fund vehicles and IPO pipelines rather than individual rounds, it signals a market entering its deployment phase: the capital is raised, the mandates are set, and the cheques will come in the quarters ahead. For APAC founders raising in Q4 2026, this week's fund closes are leading indicators of future deal flow, not evidence of a current slowdown.

For the full APAC picture across the month, see our monthly APAC funding roundup.

What was the biggest APAC capital event this week?

CCSH Corporation, the parent company of Chinese memory chip giant Yangtze Memory Technologies Corporation (YMTC), filed for a listing on the Shanghai Stock Exchange's Star Market, seeking to raise at least RMB 33bn ($4.9bn). The company will issue 1.98 to 2.43 billion shares.

The filing disclosed for the first time that Q1 2026 revenue reached RMB 48.21bn ($7.2bn) and net profit hit RMB 36.71bn ($5.4bn), more than double all of 2024, driven by the AI memory chip boom. YMTC is now the world's third-largest NAND flash chipmaker with approximately 14% market share.

This is not a startup round. But it is the defining APAC capital market event of the week and directly relevant to the startup ecosystem for three reasons. First, CCSH's filing comes two months after CXMT's $8.6bn IPO, which made the chipmaker China's most valuable listed company. Two mega-chip IPOs in consecutive months signal that Chinese semiconductor companies have reached the revenue scale to support public market valuations, creating a potential exit path for the private semiconductor startups funded at earlier stages. Second, the geopolitical dimension is inescapable: YMTC remains on the US Entity List and has been designated a PLA affiliate, yet its revenue growth is accelerating. Third, the NAND flash price surge (projected to grow 250%+ from 2024 levels) is a tailwind for every company in the AI data centre supply chain.

The announcement itself ran via Shanghai Stock Exchange filings, picked up by Nikkei Asia and KR-Asia. No media embargo, no VC press cycle. The filing was the announcement. For public-market events at this scale, the regulatory filing replaces the press strategy entirely.

Blackbird closes AUD 1.05bn fund

Blackbird, the ANZ-focused venture capital firm, closed its latest fund at more than AUD 1.05bn ($751m), which it described as the largest VC raise in Australian and New Zealand history. New investors include Morgan Stanley Investment Management, Adams Street Partners, and Schroders. Existing institutional backers include Australia's Future Fund, Aware Super, HESTA, and Hostplus.

The fund close is significant for three reasons. First, the LP composition. Morgan Stanley, Adams Street, and Schroders are global institutional allocators that typically deploy into US and European VC. Their participation in an ANZ-focused fund signals that Australia and New Zealand are now on the global institutional VC allocation map, not just a regional market served by local GPs.

Second, the scale. AUD 1.05bn is roughly double the size that would have been considered ambitious for an ANZ VC fund two years ago. Blackbird has deployed over $2.1bn and returned over $1.4bn to investors, giving it the track record to support this scale.

Third, the deployment thesis. Blackbird enters at pre-seed and seed and follows through later rounds, meaning this capital will flow through multiple stages of the ANZ startup ecosystem over the fund's life. For Australian and New Zealand founders, the message is direct: the capital is raised, the mandate is set, and Blackbird will be writing cheques at scale for the foreseeable future.

The other big APAC rounds this week

KCP (Kembangan Capital Partners), $725m first close, Singapore. Founded by former Temasek executive Koh Wai Kit, KCP raised $725m across two vehicles: $500m for fund-of-funds and $225m for direct and co-investments. An unnamed sovereign wealth fund anchored. Target sectors: AI, healthcare, consumer, and financial services across China, India, Japan, South Korea, and Southeast Asia.

The sovereign anchor is structurally important. A single sovereign committing to anchor both vehicles signals a concentrated bet on KCP's thesis rather than a diversified allocation. The fund-of-funds structure means KCP will be deploying into other APAC GPs' funds, amplifying the capital flow through the regional ecosystem.

Craif, $33m Series D, Tokyo, Japan. Urine-based early cancer detection company Craif raised approximately $33m ($30.7m equity, $3.3m debt) co-led by Granite-Integral and diagnostics company Tauns. Total raised: approximately $88m. The company is preparing for a US launch and a Japanese regulatory filing for its pancreatic cancer diagnostic. Japanese biotech reaching Series D with US market entry ambitions is a pattern that has accelerated in 2026.

Neocrete, $3.5m, New Zealand. Low-carbon concrete additive developer raised from Wavemaker Ventures (returning), Icehouse Ventures, and Temasek Trust. Neocrete's additives allow 30 to 50% cement replacement with fly ash and volcanic ash while maintaining strength. The Temasek Trust participation in a New Zealand climate tech deal demonstrates Singapore sovereign capital flowing into ANZ sustainability plays.

Buddy Bites, $4.2m Series A, Hong Kong. Pet food subscription company raised from Digitalis Ventures. First institutional round since 2020 founding. Plans to expand from Hong Kong and Singapore into Taiwan.

China venture rounds. Multiple disclosed rounds in the eight-figure RMB range, including: Cheng Bai (fragrance brand, pre-Series A from Shanghai Film New Vision Fund), Real Thermal Management Tech (aerospace thermal management, Series A+ from Innoangel Fund and others), and Pandag (commercial landscaping robotics, Series A from Seas Capital). Exact USD amounts were not disclosed for most Chinese rounds, following the typical RMB-denominated disclosure pattern.

Where is APAC capital flowing?

Fund vehicles and public-market events dominated: Blackbird ($751m fund), KCP ($725m fund), CCSH ($4.9bn IPO filing). These three events alone represent approximately $6.4bn in capital formation, dwarfing individual startup rounds.

At the startup level, Japan produced the largest single equity round (Craif, $33m). Hong Kong contributed Buddy Bites ($4.2m). New Zealand contributed Neocrete ($3.5m). China contributed multiple undisclosed-quantum venture rounds. India, which dominated the prior week with 95% of APAC deal count, was notably quieter.

The sector split at fund level was broad: Blackbird deploys across technology generally, KCP targets AI, healthcare, consumer, and financial services. At the startup level, biotech (Craif), climate tech (Neocrete), consumer (Buddy Bites, Cheng Bai), and deep tech (Real Thermal Management, Pandag) were all represented.

Dark horse: Neocrete

Neocrete, the $3.5m New Zealand concrete additive company, is this week's dark horse. Concrete production accounts for approximately 8% of global CO2 emissions, and any technology that can reduce cement usage by 30 to 50% while maintaining structural integrity addresses one of the hardest decarbonisation challenges.

The Temasek Trust participation is the signal worth tracking. Singapore sovereign-linked capital investing in a New Zealand climate materials company demonstrates the cross-APAC capital flows that are emerging beneath the China-India headline layer. Neocrete's expansion plans target Europe and the US alongside Southeast Asia, making it a genuinely global play funded from the bottom of the South Pacific.

Notable APAC launches this week

CCSH/YMTC IPO filing. China's second mega-chip IPO filing in two months. The disclosure of $7.2bn in Q1 revenue and $5.4bn in Q1 net profit, more than double all of 2024, demonstrates the AI memory chip windfall at scale.

World Robot Conference 2026, Beijing. The annual conference ran during the week, with KR-Asia noting that "robots face the test of real work." China's physical AI and robotics pipeline continues to produce at a pace that exceeds all other APAC markets combined.

CXMT becomes China's most valuable listed company. Following its July IPO, CXMT overtook Tencent in market capitalisation, an inflection point for the Chinese semiconductor industry's position in public markets.

What should APAC founders raising soon do this week?

Treat Blackbird's fund close as a deployment signal. AUD 1.05bn is raised and mandated for ANZ founders. If you are building a technology company in Australia or New Zealand and have not engaged Blackbird, the capital overhang makes this the quarter to do so.

Position for the KCP deployment window. $225m in direct and co-investment capital targeting AI, healthcare, consumer, and financial services across China, India, Japan, Korea, and SEA. KCP is a new entrant with sovereign backing and Temasek DNA. If your company fits the thesis, engage before the deployment ramp is fully underway.

Japanese biotech is reaching late stage. Craif at $33m Series D with US market entry plans shows that Japanese biotech founders can build to a point where US commercialisation is the natural next step. If you are a Japanese biotech founder, the capital is available for US regulatory and commercial buildout.

Track Temasek Trust's climate tech allocations. The Neocrete investment shows Temasek Trust deploying into climate materials outside Singapore. If you are building in the materials, construction, or decarbonisation space across APAC, Temasek Trust is a viable funder.

The rest of the week's APAC rounds

Frequently asked questions

What was the biggest APAC capital event this week? CCSH Corporation (YMTC parent) filed for a $4.9bn Shanghai IPO. At the fund level, Blackbird closed AUD 1.05bn, the largest VC raise in ANZ history.

How much did APAC startups raise in total this week? Individual startup rounds totalled approximately $45m+ in disclosed equity, but the week was dominated by fund-level activity: Blackbird ($751m fund), KCP ($725m), and CCSH's $4.9bn IPO filing.

Which APAC country raised the most? China dominated by capital volume through the CCSH IPO filing. Australia led at the fund level via Blackbird. Japan produced the largest individual startup equity round (Craif, $33m).

Who is Blackbird and why does the fund close matter? Blackbird is Australia and New Zealand's most prominent VC firm, investing from pre-seed through growth. The AUD 1.05bn close, backed by Morgan Stanley, Adams Street, and Australian sovereign investors, signals that global institutional capital now views ANZ as a viable VC allocation.

What is the CCSH/YMTC IPO about? CCSH is the listing vehicle for YMTC, the world's third-largest NAND flash chipmaker. The $4.9bn IPO filing on Shanghai's Star Market follows CXMT's $8.6bn listing in July. Both are riding the AI memory chip boom, with YMTC's Q1 2026 net profit exceeding all of 2024.

Subscribe to Ignita's free weekly newsletter for announcement teardowns that go deeper than this roundup: ignitaai.substack.com